These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1333085)

  • 1. Diprenorphine as a stimulus in drug discrimination learning.
    Smurthwaite ST; Riley AL
    Pharmacol Biochem Behav; 1992 Nov; 43(3):839-46. PubMed ID: 1333085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone as a stimulus in drug discrimination learning: generalization to other opiate antagonists.
    Smurthwaite ST; Kautz MA; Geter B; Riley AL
    Pharmacol Biochem Behav; 1992 Jan; 41(1):43-7. PubMed ID: 1539079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nalorphine as a stimulus in drug discrimination learning: assessment of the role of mu- and kappa-receptor subtypes.
    Smurthwaite ST; Riley AL
    Pharmacol Biochem Behav; 1994 Jul; 48(3):635-42. PubMed ID: 7938116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute supersensitivity to the discriminative stimulus effects of naltrexone in pigeons.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1988 Feb; 244(2):599-605. PubMed ID: 3346837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nalorphine's ability to substitute for morphine in a drug discrimination procedure is a function of training dose.
    Grabus SD; Smurthwaite ST; Riley AL
    Pharmacol Biochem Behav; 1999 Jul; 63(3):481-8. PubMed ID: 10418791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buprenorphine as a stimulus in drug discrimination learning: an assessment of mu and kappa receptor activity.
    Pournaghash S; Riley AL
    Pharmacol Biochem Behav; 1993 Nov; 46(3):593-604. PubMed ID: 8278436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey.
    DeRossett SE; Holtzman SG
    J Pharmacol Exp Ther; 1986 May; 237(2):437-44. PubMed ID: 3009783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1985 Jul; 234(1):81-9. PubMed ID: 4009506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of the interaction between cholecystokinin and the opiates within a drug discrimination procedure.
    Melton PM; Riley AL
    Pharmacol Biochem Behav; 1993 Sep; 46(1):237-42. PubMed ID: 8255917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine, saline and naltrexone discrimination in morphine-treated pigeons.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1987 Jul; 242(1):195-202. PubMed ID: 3612524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization.
    Colpaert FC; Janssen PA
    J Pharmacol Exp Ther; 1984 Jul; 230(1):193-9. PubMed ID: 6747824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization.
    White DA; Holtzman SG
    J Pharmacol Exp Ther; 2005 Jul; 314(1):374-82. PubMed ID: 15843500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist and antagonist effects of prototype opiate drugs in fentanyl dose-dose discrimination.
    Colpaert FC; Janssen PA
    Psychopharmacology (Berl); 1986; 90(2):222-8. PubMed ID: 3097702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of sigma, PCP, and opiate receptor ligands in rats trained with ibogaine as a discriminative stimulus.
    Helsley S; Filipink RA; Bowen WD; Rabin RA; Winter JC
    Pharmacol Biochem Behav; 1998 Feb; 59(2):495-503. PubMed ID: 9477000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine discriminative control is mediated by the mu opioid receptor: assessment of delta opioid substitution and antagonism.
    Stevenson GW; Cañadas F; Zhang X; Rice KC; Riley AL
    Pharmacol Biochem Behav; 2000 Aug; 66(4):851-6. PubMed ID: 10973525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug reinforcement studied by the use of place conditioning in rat.
    Mucha RF; van der Kooy D; O'Shaughnessy M; Bucenieks P
    Brain Res; 1982 Jul; 243(1):91-105. PubMed ID: 6288174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence.
    Walker EA; Sterious SN
    Br J Pharmacol; 2005 Aug; 145(7):975-83. PubMed ID: 15912139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of naloxone and diprenorphine on spontaneous activity in rats and mice.
    DeRossett SE; Holtzman SG
    Pharmacol Biochem Behav; 1982 Aug; 17(2):347-51. PubMed ID: 7134243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus properties of nalorphine in the rhesus monkeys.
    Tang AH; Code RA
    J Pharmacol Exp Ther; 1983 Dec; 227(3):563-9. PubMed ID: 6317838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey.
    White DA; Holtzman SG
    Psychopharmacology (Berl); 2003 May; 167(2):203-10. PubMed ID: 12644889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.